Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOS

BioPlus Acquisition (BIOS) Stock Price, News & Analysis

BioPlus Acquisition logo

About BioPlus Acquisition Stock (NASDAQ:BIOS)

Advanced Chart

Key Stats

Today's Range
$10.79
$10.80
50-Day Range
$10.75
$10.84
52-Week Range
$10.05
$11.68
Volume
5,636 shs
Average Volume
122,781 shs
Market Capitalization
$209.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioPlus Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BIOS Stock News Headlines

PayMate Plans to Acquire DigiAsia Bios
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this means and how everyday investors like you can position themselves to potentially profit. The timing couldn't be more critical
See More Headlines

BIOS Stock Analysis - Frequently Asked Questions

BioPlus Acquisition (BIOS) raised $180 million in an initial public offering (IPO) on Friday, December 3rd 2021. The company issued 18,000,000 shares at a price of $10.00 per share. Cantor acted as the underwriter for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that BioPlus Acquisition investors own include TransMedics Group (TMDX), Deciphera Pharmaceuticals (DCPH) and BioMarin Pharmaceutical (BMRN).

Company Calendar

Today
7/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
14,990,000
Market Cap
$209.10 million
Optionable
Not Optionable
Beta
0.01
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:BIOS) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners